TNF Deficiency Fails to Protect BAFF Transgenic Mice against Autoimmunity and Reveals a Predisposition to B Cell Lymphoma

Journal of Immunology

Volumn 172, Issue 2, 2004, Pages 812-822

  Batten, Marcel ^a   Fletcher, Carrie ^a   Ng, Lai Guan ^a   Groom, Joanna ^a   Wheway, Julie ^a   Laâbi, Yacine ^b   Xin, Xiaoguan ^a,d   Schneider, Pascal ^c   Tschopp, Jurg ^c   Mackay, Charles R ^a,d   Mackay, Fabienne ^a,d  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Coop Research Center for Asthma ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; B LYMPHOCYTE DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; CELL PROTECTION; CELL SURVIVAL; GENETIC PREDISPOSITION; GERMINAL CENTER; HOST RESISTANCE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIGAND BINDING; LYMPHOID ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENIC MOUSE;

EID: 9144234090     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.2.812     Document Type: Article

References (78)

1. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487.
2. Flavell, R. A. 2002. The relationship of inflammation and initiation of autoimmune disease: role of TNF super family members. Curr. Top. Microbiol. Immunol. 266:1.
3. Mackay, F., and S. L. Kalled. 2002. TNF ligands and receptors in autoimmunity: an update. Curr. Opin. Immunol. 14:783.
4. Mackay, F., P. Schneider, P. Rennert, and J. L. Browning. 2003. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21:231.
5. Do, R. K. G., and S. Chen-Kiang. 2002. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev. 13:19.
6. Rolink, A., J. Tschopp, P. Schneider, and F. Melchers. 2002. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 32:2004.
7. Kalled, S. L. 2002. BAFF: a novel therapeutic target for autoimmunity. Curr. Opin. Investig. Drugs 3:1005.
8. Mackay, F., and C. Ambrose. 2003. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev. 14:311.
9. Mackay, F., and J. L. Browning. 2002. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2:465.
10. MacLennan, I. C. M., and C. G. Vinuesa. 2002. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17:235.
11. Khare, S. D., I. Sarosi, X.-Z. Xia, S. McCabe, K. Miner, I. Solovyev, N. Hawkins, M. Kelley, D. Chang, D. Chang, et al. 2000. Severe B cell hyperplasia and autoimmune disease in TALL-I transgenic mice. Proc. Natl. Acad. Sci. USA 97:3370.
12. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1697.
13. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Forster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404:995.
14. Rolink, A. G., and F. Melchers. 2002. BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol. 14:266.
15. Mackay, F., and C. R. Mackay. 2002. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 23:113.
16. Cheema, G. S., V. Roschke, D. M. Hilbert, and W. Stohl. 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44:1313.
17. Groom, J., S. L. Kalled, A. H. Cutler, C. Olson, S. A. Woodcock, P. Schneider, J. Tschopp, T. G. Cachero, M. Batten, J. Wheway, et al. 2002. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109:59.
18. Mariette, X., S. Roux, J. Zhang, D. Bengoufa, F. Lavie, T. Zhou, and R. Kimberly. 2003. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann. Rheum. Dis. 62:168.
19. Zhang, J., V. Roschke, K. P. Baker, Z. Wang, G. S. Alarcon, B. J. Fessler, H. Bastian, R. P. Kimberly, and T. Zhou. 2001. A role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166:6.
20. Briones, J., J. M. Timmerman, D. M. Hilbert, and R. Levy. 2002. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp. Hematol. 30:135.
21. Novak, A. J., R. J. Bram, N. E. Kay, and D. F. Jelinek. 2002. Aberrant expression of B-lymphocyte stimulator by chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100:2973.
22. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.
23. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:1453.
24. Do, R. K., E. Hatada, H. Lee, M. R. Tourigny, D. Hilbert, and S. Chen-Kiang. 2000. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192:953.
25. Thompson, J. S., P. Schneider, S. L. Kalled, L. Wang, E. A. Lefevre, T. G. Cachero, F. Mackay, S. A. Bixler, M. Zafari, Z.-Y. Liu, et al. 2000. BAFF binds to the TNF receptor-like molecule BCMA and is important for maintaining the peripheral B cell population. J. Exp. Med. 192:129.
26. Schiemann, B., J. L. Gommerman, K. Vora, T. G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M. L. Scott. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293:2111.
27. Gross, J. A., S. R. Dillon, S. Mudri, J. Johnston, A. Littau, R. Roque, M. Rixon, O. Schou, K. P. Foley, H. Haugen, et al. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: impaired B cell maturation in mice lacking BLyS. Immunity 15:289.
28. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595.
29. Phan, T. G., M. Amesbury, S. Gardam, J. Crosbie, J. Hasbold, P. D. Hodgkin, A. Baslen, and R. Brink. 2003. B cell receptor-independent stimuli trigger immunoglobulin switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197:845.
30. Balazs, M., F. Martin, T. Zhou, and J. F. Kearney. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341.
31. Yan, M., S. A. Marsters, I. S. Grewal, H. Wang, A. Ashkenazi, and V. M. Dixit. 2000. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat. Immun. 1:37.
32. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2:323.
33. Martin, F., and J. F. Kearney. 2000. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19 and btk. Immunity 12:39.
34. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195:181.
35. Li, Y., H. Li, D. Ni, and M. Weigert. 2002. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J. Exp. Med. 196:1543.
36. Grimaldi, C. M., D. J. Michael, and B. Diamond. 2001. Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:1886.
37. Peeva, E., D. Michael, J. Cleary, J. Rice, X. Chen, and B. Diamond. 2003. Prolactin modulates the naive B cell repertoire. J. Clin. Invest. 111:275.
38. Segundo, C., C. Rodriguez, A. Garcia-Poley, M. Aguilar, I. Gavilan, C. Bellas, and J. A. Brieva. 2001. Thyroid-infiltrating B lymphocytes in Graves' disease are related to marginal zone and memory B cell compartments. Thyroid 11:525.
39. Balkwill, F. 2002. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13:135.
40. Wallgren, A., R. Festin, C. Gidlof, M. Dohlsen, T. Kalland, and T. H. Totterman. 1993. Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells. Blood 82:1230.
41. Lens, S. M., K. Tesselar, B. F. den Drijver, M. H. van Oers, and R. A. van Lier. 1996. A dual role for both CD40-ligand and TNF-α in controlling human B cell death. J. Immunol. 156:507.
42. Matsumoto, M., Y.-X. Fu, H. Molina, and D. D. Chaplin. 1997. Lymphotoxin-α-deficient and TNF receptor-I-deficient mice define developmental and functional characteristics of germinal centers. Immunol. Rev. 156:137.
43. Kosco-Vilbois, M. H., J.-Y. Bonnefoy, and Y. Chvatchko. 1997. The physiology of murine germinal center reactions. Immunol. Rev. 156:127.
44. Korner, H., E. Cretney, P. Wilhelm, J. M. Kelly, M. Roellinghoff, J. D. Sedgwick, and M. J. Smyth. 2000. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J. Exp. Med. 191:89.
45. Feldmann, M., and R. N. Maini. 2001. Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19:163.
46. Lee, D. M., and M. E. Weinblatt. 2001. Rheumatoid arthritis. Lancet 358:903.
47. Weyand, C. M., P. J. Kurtin, and J. J. Goronzy. 2001. Ectopic lymphoid organogenesis. Am. J. Pathol. 159:787.
48. Korner, H., M. Cook, D. S. Riminton, F. A. Lemckert, R. M. Hoek, B. Ledermann, F. Kontgen, B. Fazekas de St. Groth, and J. D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur. J. Immunol. 27:2600.
49. Schneider, P., F. Mackay, V. Steiner, K. Hofmann, J. L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, et al. 1999. BAFF, a novel ligand of the tumor necrosis factor (TNF) family, stimulates B-cell growth. J. Exp. Med. 189:1747.
50. Mackay, F., G. R. Majeau, P. Lawton, P. S. Hochman, and J. L. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033.
51. Matsumoto, M., S. Mariathasan, M. H. Nahm, F. Baranyay, J. J. Peschon, and D. D. Chaplin. 1996. Role of lymphotoxin and the type 1 TNF receptor in the formation of germinal centers. Science 271:1289.
52. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kolias. 1996. Immune and inflammatory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397.
53. Maes, B., and C. De Wolf-Peeters. 2002. Marginal zone cell lymphoma: an update on recent advances. Histopathology 40:117.
54. Franco, V., A. M. Florena, and E. Iannitto. 2003. Splenic marginal zone lymphoma. Blood 101:2464.
55. Calvert, R. J., P. A. Evans, J. A. Randerson, A. S. Jack, G. J. Morgan, and M. F. Dixon. 1996. The significance of B-cell clonality in gastric lymphoid infiltrates. J. Pathol. 180:26.
56. Von Bulow, G.-U., J. M. van Deursen, and R. J. Bram. 2001. Regulation of the T-independent humoral response by TACI. Immunity 14:573.
57. Yan, M., H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I. S. Grewal, and V. M. Dixit. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immun. 2:638.
58. Seshasayee, D., P. Valdez, M. Yan, V. M. Dixit, D. Tumas, and I. S. Grewal. 2003. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18:279.
59. D'Haens, G. 2003. Anti-TNF therapy for Crohn's disease. Curr. Pharm. Des. 9:289.
60. 1 mice with established nephritis: preservation of kidney function. J. Immunol. 160:2158.
61. MacLennan, I. C. M. 1994. Germinal centers. Annu. Rev. Immunol. 12:117.
62. Van Eijk, M., T. Defrance, A. Hennino, and C. de Groot. 2001. Death-receptor contribution to the germinal-center reaction. Trends Immunol. 22:677.
63. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immun. 1:469.
64. Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire: marginal zone and B1 B cells as part of a "natural immune memory." Immunol. Rev. 175:70.
65. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20:253.
66. Litinskiy, M., B. Nardelli, B. M. Hilbert, H. Bing, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immun. 3:822.
67. Fargarasan, S., and T. Honjo. 2003. Intestinal IgA synthesis: regulation of frontline body defenses. Nat. Rev. Immunol. 3:63.
68. Donadio, J. V., and J. P. Grande. 2002. IgA nephropathy. N. Engl. J. Med. 347:738.
69. Zeng, D., M.-K. Lee, J. Tung, A. Brendolan, and S. Strober. 2000. A role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164:5000.
70. 1 mice. Lupus 11:277.
71. Amano, H., E. Amano, T. Moll, D. Marinkovic, N. Ibnou-Zekri, E. Martinez-Soria, I. Semac, T. Wirth, L. Nitschke, and S. Izui. 2003. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J. Immunol. 170:2293.
72. Morse, H. C.: III, J. F. Kearney, P. G. Isaacson, M. Carroll, T. N. Fredrickson, and E. S. Jaffe. 2001. Cells of the marginal zone: origins, function and neoplasia. Leuk. Res. 25:169.
73. Tartaglia, L. A., D. V. Goeddel, C. Reynolds, I. S. Figari, R. F. Weber, B. M. Fendly, and M. A. Palladino, Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151:4637.
74. Kollias, G., and D. Kontoyiannis. 2002. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev. 13:315.
75. Huard, B., P. Schneider, D. Mauri, J. Tschopp, and L. E. French. 2001. T cell costimulation by the TNF ligand BAFF. J. Immunol. 167:6225.
76. + T cells. Nature 369:654.
77. Abbondanzo, S. L. 2001. Extranodal marginal-zone B-cell lymphoma of the salivary gland. Ann. Diagn. Pathol. 5:246.
78. Brown, S. L., M. H. Greene, S. K. Gershon, E. T. Edwards, and M. M. Braun. 2002. Tumor necrosis factor antagonist therapy and lymphoma development. Arthritis Rheum. 46:3151.